The Challenge
Where innovation could be life changing, life science and pharmaceutical companies need to find ways to prevent greater regulatory scrutiny from delaying the delivery of medical devices and products. The need to accelerate the time to market is more apparent than ever; yet companies must navigate and comply with strict regulatory requirements to do so. The underlying challenge is the lack of integration across supply chain partners. Data flow between the different divisions, facilities, suppliers, and other partners is complex and prone to delays. For life science and pharmaceutical companies, delays can be crippling.
The Solution
We help life science and pharmaceutical companies keep a beat ahead by providing solutions to classify and ship samples, leverage CAPA, track equipment, and facilitate imports and exports by generating documents such as TSCA & HazMat, Clinical Invoices, and Certificates of Analysis.

As regulations are becoming more burdensome, Integration Point clients use our GTM platform to not only manage these complex regulations but also gain business value through our centralized platform. Through a configurable platform with integrated trade data, pharmaceutical companies no longer have to worry about the possibility of delayed shipments caused by incomplete or incorrect data as well as costly customs fines or penalties due to noncompliance. Furthermore, a GTM platform facilities the flow of information throughout your supply chain, ensuring that all your partners have the most up-to-date information.
The Benefits
  • Satisfy Corrective and Preventive Action (CAPA) reporting requirements
  • Comply with industry specific PGA regulations to prevent border delays and inspections
  • Manage non-ERP originating shipments such as R&D sample shipments
  • Implement a global duty deferral strategy across the entire supply chain such as FTZ, IMMEX,
    Trade Zone, EU Customs Regimes, PTR, and more
  • Put procedures and controls in place to ensure compliant shipments across the supply chain
  • Improve insight into sourcing decisions, landed cost, risk, and the impact to the bottom line
  • Perform “what if” scenarios and trade data analysis across all regions and business units

In the United States, the FDA’s Drug Supply Chain Security Act calls for the pharma supply chain to create an “electronic, interoperable system to identify and trace certain specific drugs as they are distributed in the United States" – with compliance expected by 2023.Supply Chain Digital

of the 2016 Fortune Global 500 pharmaceutical companies are Integration Point clients
import shipments managed annually for one pharmaceutical client
reduction in entry costs by automating your import compliance process
Our clients are industry leaders
Astra Zeneca
BSN Medical
Boehringer Ingelheim
Sunrise Medical

Spanning all Industries

Integration Point helps companies of all sizes and all industries automate compliance processes, increase visibility into the supply chain, and identify savings opportunities.